These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28337723)

  • 1. Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Hatano K; Ishiwata K; Toyohara J
    EJNMMI Res; 2017 Dec; 7(1):26. PubMed ID: 28337723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.
    Toyohara J; Sakata M; Hatano K; Yanai S; Endo S; Ishibashi K; Wagatsuma K; Ishii K; Ishiwata K
    Ann Nucl Med; 2016 Oct; 30(8):534-43. PubMed ID: 27329083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM.
    Toyohara J; Sakata M; Oda K; Ishii K; Ito K; Hiura M; Fujinaga M; Yamasaki T; Zhang MR; Ishiwata K
    J Nucl Med; 2013 Aug; 54(8):1302-7. PubMed ID: 23804329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 5. First clinical assessment of [
    Toyohara J; Sakata M; Ishibashi K; Mossel P; Imai M; Wagatsuma K; Tago T; Imabayashi E; Colabufo NA; Luurtsema G; Ishii K
    Ann Nucl Med; 2021 Nov; 35(11):1240-1252. PubMed ID: 34368924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [ (11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ (11)C](R)-PK11195.
    Hatano K; Sekimata K; Yamada T; Abe J; Ito K; Ogawa M; Magata Y; Toyohara J; Ishiwata K; Biggio G; Serra M; Laquintana V; Denora N; Latrofa A; Trapani G; Liso G; Suzuki H; Sawada M; Nomura M; Toyama H
    Ann Nucl Med; 2015 May; 29(4):325-35. PubMed ID: 25616581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis.
    Vállez Garcia D; de Vries EF; Toyohara J; Ishiwata K; Hatano K; Dierckx RA; Doorduin J
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1106-18. PubMed ID: 25771904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry and efficacy of a tau PET tracer [
    Ohnishi A; Akamatsu G; Ikari Y; Nishida H; Shimizu K; Matsumoto K; Aita K; Sasaki M; Yamamoto Y; Yamane T; Senda M
    Ann Nucl Med; 2023 Feb; 37(2):108-120. PubMed ID: 36411357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.
    Lohith TG; Zoghbi SS; Morse CL; Araneta MF; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
    J Nucl Med; 2012 Mar; 53(3):385-92. PubMed ID: 22312136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
    Luoto P; Suilamo S; Oikonen V; Arponen E; Helin S; Herttuainen J; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Scheinin M; Virta J; Virtanen K; Volanen I; Roivainen A; Rinne JO
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1947-56. PubMed ID: 24838249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (¹⁸F) injection in healthy Japanese adult volunteers.
    Senda M; Brooks DJ; Farrar G; Somer EJ; Paterson CL; Sasaki M; McParland BJ
    Ann Nucl Med; 2015 Aug; 29(7):627-35. PubMed ID: 26044876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.
    Toyohara J; Nariai T; Sakata M; Oda K; Ishii K; Kawabe T; Irie T; Saga T; Kubota K; Ishiwata K
    J Nucl Med; 2011 Aug; 52(8):1322-8. PubMed ID: 21764794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
    Brody AL; Okita K; Shieh J; Liang L; Hubert R; Mamoun M; Farahi J; Mandelkern MA
    Nucl Med Biol; 2014; 41(10):871-5. PubMed ID: 25156039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and Radiation Dosimetry of
    Garg PK; Lokitz SJ; Nazih R; Garg S
    J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.
    Takano A; Gulyás B; Varrone A; Karlsson P; Sjoholm N; Larsson S; Jonsson C; Odh R; Sparks R; Al Tawil N; Hoffmann A; Zimmermann T; Thiele A; Halldin C
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2058-65. PubMed ID: 21732107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
    J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
    Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
    Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D
    Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation.
    Hirvonen J; Roivainen A; Virta J; Helin S; Någren K; Rinne JO
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):606-12. PubMed ID: 19862517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.